Grippaudo Francesca Romana, Migliano Emilia, Redi Ugo, Turriziani Gianmarco, Marino Davide, D'Ermo Giuseppe, Ribuffo Diego
Department of Surgery "P. Valdoni", Sapienza University of Rome, Rome, Italy.
Plastic and Regenerative Surgery Dept., San Gallicano Dermatological Institute IRCCS, Rome, Italy.
Eur J Plast Surg. 2020;43(5):645-650. doi: 10.1007/s00238-020-01725-w. Epub 2020 Aug 26.
COVID-19 is a new human-infecting coronavirus for which the World Health Organization declared a global pandemic. The first Italian cases occurred in February 2020: since then, there has been an exponential increase in new cases, hospitalizations and intensive care assistance demand. This new and sudden scenario led to a forced National Health System reorganization and review of welfare priorities. The aim of this study is to evaluate the effects of this pandemic on ordinary activities in two plastic surgery divisions in Rome, hosted in a COVID-19 and a non-COVID-19 hospital.
The data of this comparative retrospective study was collected between 9 March and 9 April 2019 and the same period of 2020 from two plastic surgery units, one in a COVID-19 hospital and second in a non-COVID-19 hospital in Rome, Italy. The 2019-2020 data of the two hospitals was compared regarding the number of surgeries, post-operative dressings and first consultations performed.
Both units sustained a decrease in workload due to lockdown effects. Statistically significant differences for day surgery procedures ( value = 0.0047) and first consultations ( value < 0.0001) were found between the COVID-19 and non-COVID-19 institutes, with a drastic trend limiting non-urgent access to COVID-19 hospitals.
The long-term effects of healthcare reshuffling in the "COVID-19 era" imply a delay in the diagnosis and treatment of skin cancer and cancellation of many reconstructive procedures. These findings pose a question on the future consequences of a long-term limitation in plastic surgery healthcare.Level of evidence: Level III, risk/prognostic study.
新型冠状病毒肺炎（COVID-19）是一种新的感染人类的冠状病毒，世界卫生组织已宣布其为全球大流行病。意大利首例病例于2020年2月出现，自那时起，新增病例、住院人数及重症监护需求呈指数级增长。这种新出现的突发情况导致国家卫生系统被迫进行重组，并重新审视福利重点。本研究旨在评估这场大流行病对罗马两个整形外科科室日常活动的影响，这两个科室分别设在一家收治COVID-19患者的医院和一家未收治COVID-19患者的医院。
本比较性回顾性研究的数据收集于2019年3月9日至4月9日以及2020年同期，来自意大利罗马一家收治COVID-19患者的医院和一家未收治COVID-19患者的医院的两个整形外科科室。比较了两家医院2019 - 2020年期间的手术数量、术后换药次数及首次会诊次数。
由于封锁措施的影响，两个科室的工作量均有所下降。在COVID-19医院和非COVID-19医院之间，日间手术（ 值 = 0.0047）和首次会诊（ 值 < 0.0001）存在统计学上的显著差异，呈现出一种明显的趋势，即限制非紧急情况下前往COVID-19医院就诊。
“COVID-19时代”医疗资源重新调配的长期影响意味着皮肤癌诊断和治疗的延迟以及许多重建手术的取消。这些发现引发了关于整形外科医疗长期受限的未来后果的疑问。证据级别：三级，风险/预后研究。
